请输入您要查询的百科知识：

　

词条 ATM serine/threonine kinase
释义

  1. Introduction

  2. Structure

  3. Function

  4. Regulation

  5. Role in cancer

  6. ATM mutation frequencies in sporadic cancers

  7. Frequent epigenetic deficiencies of ATM in cancers

  8. Meiosis

  9. Interactions

  10. Tefu

  11. See also

  12. References

  13. Further reading

  14. External links

{{About|the ATM protein|the ATM cell type|adipose tissue macrophages}}{{Infobox_gene}}

ATM serine/threonine kinase, symbol ATM, is a serine/threonine protein kinase that is recruited and activated by DNA double-strand breaks. It phosphorylates several key proteins that initiate activation of the DNA damage checkpoint, leading to cell cycle arrest, DNA repair or apoptosis. Several of these targets, including p53, CHK2, BRCA1, NBS1 and H2AX are tumor suppressors.

The protein was named for the disorder ataxia–telangiectasia caused by mutations of ATM.[1]

Introduction

Throughout the cell cycle DNA is monitored for damage. Damages result from errors during replication, by-products of metabolism, general toxic drugs or ionizing radiation. The cell cycle has different DNA damage checkpoints, which inhibit the next or maintain the current cell cycle step. There are two main checkpoints, the G1/S and the G2/M, during the cell cycle, which preserve correct progression. ATM plays a role in cell cycle delay after DNA damage, especially after double-strand breaks (DSBs).[2] ATM together with NBS1 act as primary DSB sensor proteins. Different mediators, such as Mre11 and MDC1, acquire post-translational modifications which are generated by the sensor proteins. These modified mediator proteins then amplify the DNA damage signal, and transduce the signals to downstream effectors such as CHK2 and p53.

Structure

The ATM gene codes for a 350 kDa protein consisting of 3056 amino acids.[3] ATM belongs to the superfamily of phosphatidylinositol 3-kinase-related kinases (PIKKs). The PIKK superfamily comprises six Ser/Thr-protein kinases that show a sequence similarity to phosphatidylinositol 3-kinases (PI3Ks). This protein kinase family includes ATR (ATM- and RAD3-related), DNA-PKcs (DNA-dependent protein kinase catalytic subunit) and mTOR (mammalian target of rapamycin). Characteristic for ATM are five domains. These are from N-terminus to C-terminus the HEAT repeat domain, the FRAP-ATM-TRRAP (FAT) domain, the kinase domain (KD), the PIKK-regulatory domain (PRD) and the FAT-C-terminal (FATC) domain. The HEAT repeats directly bind to the C-terminus of NBS1. The FAT domain interacts with ATM's kinase domain to stabilize the C-terminus region of ATM itself. The KD domain resumes kinase activity, while the PRD and the FATC domain regulate it. Although no structure for ATM has been solved, the overall shape of ATM is very similar to DNA-PKcs and is composed of a head and a long arm that is thought to wrap around double-stranded DNA after a conformational change. The entire N-terminal domain together with the FAT domain are predicted to adopt an α-helical structure, which was found by sequence analysis. This α-helical structure is believed to form a tertiary structure, which has a curved, tubular shape present for example in the Huntingtin protein, which also contains HEAT repeats. FATC is the C-terminal domain with a length of about 30 amino acids. It is highly conserved and consists of an α-helix followed by a sharp turn, which is stabilized by a disulfide bond.[4]

Function

A complex of the three proteins MRE11, RAD50 and NBS1 (XRS2 in yeast), called the MRN complex in humans, recruits ATM to double strand breaks (DSBs) and holds the two ends together. ATM directly interacts with the NBS1 subunit and phosphorylates the histone variant H2AX on Ser139.[5] This phosphorylation generates binding sites for adaptor proteins with a BRCT domain. These adaptor proteins then recruit different factors including the effector protein kinase CHK2 and the tumor suppressor p53. The ATM-mediated DNA damage response consists of a rapid and a delayed response. The effector kinase CHK2 is phosphorylated and thereby activated by ATM. Activated CHK2 phosphorylates phosphatase CDC25A, which is degraded thereupon and can no longer dephosphorylate CDK1-cyclin B, resulting in cell-cycle arrest. If the DSB can not be repaired during this rapid response, ATM additionally phosphorylates MDM2 and p53 at Ser15.[6] p53 is also phosphorylated by the effector kinase CHK2. These phosphorylation events lead to stabilization and activation of p53 and subsequent transcription of numerous p53 target genes including CDK inhibitor p21 which lead to long-term cell-cycle arrest or even apoptosis.[7]

The protein kinase ATM may also be involved in mitochondrial homeostasis, as a regulator of mitochondrial autophagy (mitophagy) whereby old, dysfunctional mitochondria are removed.[8] Increased ATM activity also occurs in viral infection where ATM is activated early during dengue virus infection as part of autophagy induction and ER stress response.[9]

Regulation

A functional MRN complex is required for ATM activation after DSBs. The complex functions upstream of ATM in mammalian cells and induces conformational changes that facilitate an increase in the affinity of ATM towards its substrates, such as CHK2 and p53.[2]

Inactive ATM is present in the cells without DSBs as dimers or multimers. Upon DNA damage, ATM autophosphorylates on residue Ser1981. This phosphorylation provokes dissociation of ATM dimers, which is followed by the release of active ATM monomers.[10] Further autophosphorylation (of residues Ser367 and Ser1893) is required for normal activity of the ATM kinase. Activation of ATM by the MRN complex is preceded by at least two steps, i.e. recruitment of ATM to DSB ends by the mediator of DNA damage checkpoint protein 1 (MDC1) which binds to MRE11, and the subsequent stimulation of kinase activity with the NBS1 C-terminus.

The three domains FAT, PRD and FATC are all involved in regulating the activity of the KD kinase domain. The FAT domain interacts with ATM's KD domain to stabilize the C-terminus region of ATM itself. The FATC domain is critical for kinase activity and highly sensitive to mutagenesis. It mediates protein-protein interaction for example with the histone acetyltransferase TIP60 (HIV-1 Tat interacting protein 60 kDa), which acetylates ATM on residue Lys3016. The acetylation occurs in the C-terminal half of the PRD domain and is required for ATM kinase activation and for its conversion into monomers. While deletion of the entire PRD domain abolishes the kinase activity of ATM, specific small deletions show no effect.[4]

Role in cancer

Ataxia–telangiectasia (AT) is a rare human disease characterized by cerebellar degeneration, extreme cellular sensitivity to radiation and a predisposition to cancer. All AT patients contain mutations in the ATM gene. Most other AT-like disorders are defective in genes encoding the MRN protein complex. One feature of the ATM protein is its rapid increase in kinase activity immediately following double-strand break formation.[11][12] The phenotypic manifestation of AT is due to the broad range of substrates for the ATM kinase, involving DNA repair, apoptosis, G1/S, intra-S checkpoint and G2/M checkpoints, gene regulation, translation initiation, and telomere maintenance.[13] Therefore, a defect in ATM has severe consequences in repairing certain types of damage to DNA, and cancer may result from improper repair. AT patients have an increased risk for breast cancer that has been ascribed to ATM's interaction and phosphorylation of BRCA1 and its associated proteins following DNA damage.[14] Certain kinds of leukemias and lymphomas, including mantle cell lymphoma, T-ALL, atypical B cell chronic lymphocytic leukemia, and T-PLL are also associated with ATM defects.[15]

ATM mutation frequencies in sporadic cancers

Mutations in the ATM gene are found at relatively low frequencies in sporadic cancers. According to COSMIC, the Catalogue Of Somatic Mutations In Cancer, the frequencies with which heterozygous mutations in ATM are found in common cancers include 0.7% in 713 ovarian cancers, 0.9% in central nervous system cancers, 1.9% in 1,120 breast cancers, 2.1% in 847 kidney cancers, 4.6% in colon cancers, 7.2% among 1,040 lung cancers and 11.1% in 1790 hematopoetic and lymphoid tissue cancers.[16]

Frequent epigenetic deficiencies of ATM in cancers

ATM is one of the DNA repair genes frequently hypermethylated in its promoter region in various cancers (see table of such genes in Cancer epigenetics). The promoter methylation of ATM causes reduced protein or mRNA expression of ATM.

More than 73% of brain tumors were found to be methylated in the ATM gene promoter and there was strong inverse correlation between ATM promoter methylation and its protein expression (p < 0.001).[17]

The ATM gene promoter was observed to be hypermethylated in 53% of small (impalpable) breast cancers[18] and was hypermethylated in 78% of stage II or greater breast cancers with a highly significant correlation (P = 0.0006) between reduced ATM mRNA abundance and aberrant methylation of the ATM gene promoter.[19]

In non-small cell lung cancer (NSCLC), the ATM promoter methylation status of paired tumors and surrounding histologically uninvolved lung tissue was found to be 69% and 59%, respectively. However, in more advanced NSCLC the frequency of ATM promoter methylation was lower at 22%.[20] The finding of ATM promoter methylation in surrounding histologically uninvolved lung tissue suggests that ATM deficiency may be present early in a field defect leading to progression to NSCLC.

In squamous cell carcinoma of the head and neck, 42% of tumors displayed ATM promoter methylation.[21]

DNA damage appears to be the primary underlying cause of cancer,[22][23] and deficiencies in DNA repair likely underlie many forms of cancer.[24] If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase mutational errors during DNA replication due to error-prone translesion synthesis. Excess DNA damage may also increase epigenetic alterations due to errors during DNA repair.[25][26] Such mutations and epigenetic alterations may give rise to cancer. The frequent epigenetic deficiency of ATM in a number of cancers likely contributed to the progression of those cancers.

Meiosis

ATM functions during meiotic prophase.[27] The wild-type ATM gene is expressed at a four-fold increased level in human testes compared to somatic cells (such as skin fibroblasts).[28] In both mice and humans, ATM deficiency results in female and male infertility. Deficient ATM expression causes severe meiotic disruption during prophase I.[29] In addition, impaired ATM-mediated DNA DSB repair has been identified as a likely cause of aging of mouse and human oocytes.[30] Expression of the ATM gene, as well as other key DSB repair genes, declines with age in mouse and human oocytes and this decline is paralleled by an increase of DSBs in primordial follicles.[30] These findings indicate that ATM-mediated homologous recombinational repair is a crucial function of meiosis.

Interactions

Ataxia telangiectasia mutated has been shown to interact with:

{{div col|colwidth=20em}}
  • Abl gene,[36][37][31]
  • BRCA1,[14][40][41][32][33][34][35]
  • Bloom syndrome protein,[41][36]
  • DNA-PKcs,[40][37]
  • FANCD2,[38][39]
  • MRE11A,[40][41]
  • Nibrin,[40][40]
  • P53,[40][41][42][43][44]
  • RAD17,[45][46]
  • RAD51,[47]
  • RBBP8,[45][48]
  • RHEB,[49]
  • RRM2B,[50]
  • SMC1A[51]
  • TERF1,[52] and
  • TP53BP1.[53][54]
{{Div col end}}

Tefu

The Tefu protein of Drosophila melanogaster is a structural and functional homolog of the human ATM protein.[55] Tefu, like ATM, is required for DNA repair and normal levels of meiotic recombination in oocytes.

See also

  • Ataxia telangiectasia
  • Ataxia telangiectasia and Rad3 related

References

1. ^{{cite web | title = Entrez Gene: ATM ataxia telangiectasia mutated (includes complementation groups A, C and D)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=472| accessdate = }}
2. ^1 {{cite journal | vauthors = Lee JH, Paull TT | title = Activation and regulation of ATM kinase activity in response to DNA double-strand breaks | journal = Oncogene | volume = 26 | issue = 56 | pages = 7741–8 | date = December 2007 | pmid = 18066086 | doi = 10.1038/sj.onc.1210872 }}
3. ^{{cite web |url=https://www.uniprot.org/uniprot/Q13315#ref33 |title=Serine-protein kinase ATM - Homo sapiens (Human) |work= |accessdate=}}
4. ^1 2 {{cite journal | vauthors = Lempiäinen H, Halazonetis TD | title = Emerging common themes in regulation of PIKKs and PI3Ks | journal = EMBO J. | volume = 28 | issue = 20 | pages = 3067–73 | date = October 2009 | pmid = 19779456 | pmc = 2752028 | doi = 10.1038/emboj.2009.281 }}
5. ^{{cite journal | vauthors = Huang X, Halicka HD, Darzynkiewicz Z | title = Detection of histone H2AX phosphorylation on Ser-139 as an indicator of DNA damage (DNA double-strand breaks) | journal = Curr Protoc Cytom | volume = Chapter 7 | issue = | pages = Unit 7.27 | date = November 2004 | pmid = 18770804 | doi = 10.1002/0471142956.cy0727s30 | isbn = 0-471-14295-6 }}
6. ^{{cite journal | vauthors = Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD | title = Activation of the ATM kinase by ionizing radiation and phosphorylation of p53 | journal = Science | volume = 281 | issue = 5383 | pages = 1677–9 | date = September 1998 | pmid = 9733515 | doi = 10.1126/science.281.5383.1677 }}
7. ^1 {{cite book |last= Morgan |first= David O.|title= Principles of Control |publisher= Oxford University Press |year= 2007 |isbn= 0-19-920610-4}}
8. ^{{cite journal | vauthors = Valentin-Vega YA, Maclean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, Cleveland JL, Green DR, Kastan MB | title = Mitochondrial dysfunction in ataxia-telangiectasia | journal = Blood | volume = 119 | issue = 6 | pages = 1490–500 | year = 2012 | pmid = 22144182 | pmc = 3286212 | doi = 10.1182/blood-2011-08-373639 }}
9. ^{{cite journal | journal = Cell Death and Disease | title = Dengue-induced autophagy, virus replication and protection from cell death require ER stress (PERK) pathway activation | volume = 7 | issue = e2127 | year = 2016 |vauthors=Datan E, Roy SG, Germain G, Zali N, McLean JE, Harbajan S, Lockshin RA, Zakeri Z | pmid = 26938301 | doi=10.1038/cddis.2015.409 | pmc=4823927}}
10. ^{{cite journal | vauthors = Bakkenist CJ, Kastan MB | title = DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation | journal = Nature | volume = 421 | issue = 6922 | pages = 499–506 | date = January 2003 | pmid = 12556884 | doi = 10.1038/nature01368 }}
11. ^{{cite journal | vauthors = Canman CE, Lim DS | title = The role of ATM in DNA damage responses and cancer | journal = Oncogene | volume = 17 | issue = 25 | pages = 3301–8 | date = December 1998 | pmid = 9916992 | doi = 10.1038/sj.onc.1202577 }}
12. ^{{cite journal | vauthors = Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y | title = Enhanced phosphorylation of p53 by ATM in response to DNA damage | journal = Science | volume = 281 | issue = 5383 | pages = 1674–7 | date = September 1998 | pmid = 9733514 | doi = 10.1126/science.281.5383.1674 }}
13. ^{{cite journal | vauthors = Kurz EU, Lees-Miller SP | title = DNA damage-induced activation of ATM and ATM-dependent signaling pathways | journal = DNA Repair (Amst.) | volume = 3 | issue = 8–9 | pages = 889–900 | year = 2004 | pmid = 15279774 | doi = 10.1016/j.dnarep.2004.03.029 }}
14. ^1 {{cite journal | vauthors = Chen J | title = Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage | journal = Cancer Res. | volume = 60 | issue = 18 | pages = 5037–9 | date = September 2000 | pmid = 11016625 | doi = }}
15. ^{{cite journal | vauthors = Friedenson B | title = The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers | journal = BMC Cancer | volume = 7 | pages = 152 | year = 2007 | pmid = 17683622 | pmc = 1959234 | doi = 10.1186/1471-2407-7-152 | laysummary = http://www.dnatube.com/video/1384/The-BRCA12-pathway-prevents-leukemias-and-lymphomas | laysource = Scientific Video Site }}
16. ^{{cite journal |vauthors=Cremona CA, Behrens A |title=ATM signalling and cancer |journal=Oncogene |volume=33 |issue=26 |pages=3351–60 |year=2014 |pmid=23851492 |doi=10.1038/onc.2013.275 |url=}}
17. ^{{cite journal |vauthors=Mehdipour P, Karami F, Javan F, Mehrazin M |title=Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory |journal=Mol. Neurobiol. |volume=52 |issue=1 |pages=293–302 |year=2015 |pmid=25159481 |doi=10.1007/s12035-014-8864-9 |url=}}
18. ^{{cite journal |vauthors=Delmonico L, Moreira Ados S, Franco MF, Esteves EB, Scherrer L, Gallo CV, do Nascimento CM, Ornellas MH, de Azevedo CM, Alves G |title=CDKN2A (p14(ARF)/p16(INK4a)) and ATM promoter methylation in patients with impalpable breast lesions |journal=Hum. Pathol. |volume=46 |issue=10 |pages=1540–7 |year=2015 |pmid=26255234 |doi=10.1016/j.humpath.2015.06.016 |url=}}
19. ^{{cite journal |vauthors=Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD |title=The ATM gene is a target for epigenetic silencing in locally advanced breast cancer |journal=Oncogene |volume=23 |issue=58 |pages=9432–7 |year=2004 |pmid=15516988 |doi=10.1038/sj.onc.1208092 |url=}}
20. ^{{cite journal |vauthors=Safar AM, Spencer H, Su X, Coffey M, Cooney CA, Ratnasinghe LD, Hutchins LF, Fan CY |title=Methylation profiling of archived non-small cell lung cancer: a promising prognostic system |journal=Clin. Cancer Res. |volume=11 |issue=12 |pages=4400–5 |year=2005 |pmid=15958624 |doi=10.1158/1078-0432.CCR-04-2378 |url=}}
21. ^{{cite journal |vauthors=Bolt J, Vo QN, Kim WJ, McWhorter AJ, Thomson J, Hagensee ME, Friedlander P, Brown KD, Gilbert J |title=The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms |journal=Oral Oncol. |volume=41 |issue=10 |pages=1013–20 |year=2005 |pmid=16139561 |doi=10.1016/j.oraloncology.2005.06.003 |url=}}
22. ^{{vcite2 journal |vauthors=Kastan MB |title=DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture |journal=Mol. Cancer Res. |volume=6 |issue=4 |pages=517–24 |year=2008 |pmid=18403632 |doi=10.1158/1541-7786.MCR-08-0020 |url=}}
23. ^Bernstein C, Prasad AR, Nfonsam V, Bernstein H. (2013). DNA Damage, DNA Repair and Cancer, New Research Directions in DNA Repair, Prof. Clark Chen (Ed.), {{ISBN|978-953-51-1114-6}}, InTech, http://www.intechopen.com/books/new-research-directions-in-dna-repair/dna-damage-dna-repair-and-cancer
24. ^{{cite journal |vauthors=Harper JW, Elledge SJ |title=The DNA damage response: ten years after |journal=Mol. Cell |volume=28 |issue=5 |pages=739–45 |year=2007 |pmid=18082599 |doi=10.1016/j.molcel.2007.11.015 |url=}}
25. ^{{cite journal | vauthors = O'Hagan HM, Mohammad HP, Baylin SB | title = Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island | journal = PLoS Genetics | volume = 4 | issue = 8 | pages = e1000155 | year = 2008 | pmid = 18704159 | pmc = 2491723 | doi = 10.1371/journal.pgen.1000155 }}
26. ^{{cite journal | vauthors = Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV | title = DNA damage, homology-directed repair, and DNA methylation | journal = PLoS Genetics | volume = 3 | issue = 7 | pages = e110 | date = Jul 2007 | pmid = 17616978 | pmc = 1913100 | doi = 10.1371/journal.pgen.0030110 }}
27. ^{{cite journal |vauthors=Hamer G, Kal HB, Westphal CH, Ashley T, de Rooij DG |title=Ataxia telangiectasia mutated expression and activation in the testis |journal=Biol. Reprod. |volume=70 |issue=4 |pages=1206–12 |year=2004 |pmid=14681204 |doi=10.1095/biolreprod.103.024950 |url=}}
28. ^{{cite journal |vauthors=Galetzka D, Weis E, Kohlschmidt N, Bitz O, Stein R, Haaf T |title=Expression of somatic DNA repair genes in human testes |journal=J. Cell. Biochem. |volume=100 |issue=5 |pages=1232–9 |year=2007 |pmid=17177185 |doi=10.1002/jcb.21113 |url=}}
29. ^{{cite journal |vauthors=Barlow C, Liyanage M, Moens PB, Tarsounas M, Nagashima K, Brown K, Rottinghaus S, Jackson SP, Tagle D, Ried T, Wynshaw-Boris A |title=Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I |journal=Development |volume=125 |issue=20 |pages=4007–17 |year=1998 |pmid=9735362 |doi= |url=}}
30. ^1 {{cite journal |vauthors=Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, Dickler M, Robson M, Moy F, Goswami S, Oktay K |title=Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans |journal=Sci Transl Med |volume=5 |issue=172 |pages=172ra21 |year=2013 |pmid=23408054 |doi=10.1126/scitranslmed.3004925 |pmc=5130338}}
31. ^{{cite journal | vauthors = Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T, Hobson K, Gatei M, Zhang N, Watters D, Egerton M, Shiloh Y, Kharbanda S, Kufe D, Lavin MF | title = Interaction between ATM protein and c-Abl in response to DNA damage | journal = Nature | volume = 387 | issue = 6632 | pages = 520–3 | date = May 1997 | pmid = 9168117 | doi = 10.1038/387520a0 }}
32. ^{{cite journal | vauthors = Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK | title = Role for ATM in DNA damage-induced phosphorylation of BRCA1 | journal = Cancer Res. | volume = 60 | issue = 12 | pages = 3299–304 | date = June 2000 | pmid = 10866324 | doi = }}
33. ^{{cite journal | vauthors = Cortez D, Wang Y, Qin J, Elledge SJ | title = Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks | journal = Science | volume = 286 | issue = 5442 | pages = 1162–6 | date = November 1999 | pmid = 10550055 | doi = 10.1126/science.286.5442.1162 }}
34. ^{{cite journal | vauthors = Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT | title = Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress | journal = Genes Dev. | volume = 14 | issue = 23 | pages = 2989–3002 | date = Dec 2000 | pmid = 11114888 | pmc = 317107 | doi = 10.1101/gad.851000 }}
35. ^{{cite journal | vauthors = Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK | title = Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies | journal = J. Biol. Chem. | volume = 276 | issue = 20 | pages = 17276–80 | date = May 2001 | pmid = 11278964 | doi = 10.1074/jbc.M011681200 }}
36. ^{{cite journal | vauthors = Beamish H, Kedar P, Kaneko H, Chen P, Fukao T, Peng C, Beresten S, Gueven N, Purdie D, Lees-Miller S, Ellis N, Kondo N, Lavin MF | title = Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM | journal = J. Biol. Chem. | volume = 277 | issue = 34 | pages = 30515–23 | date = August 2002 | pmid = 12034743 | doi = 10.1074/jbc.M203801200 }}
37. ^{{cite journal | vauthors = Suzuki K, Kodama S, Watanabe M | title = Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation | journal = J. Biol. Chem. | volume = 274 | issue = 36 | pages = 25571–5 | date = September 1999 | pmid = 10464290 | doi = 10.1074/jbc.274.36.25571 }}
38. ^{{cite journal | vauthors = Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD | title = Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways | journal = Cell | volume = 109 | issue = 4 | pages = 459–72 | date = May 2002 | pmid = 12086603 | doi = 10.1016/s0092-8674(02)00747-x }}
39. ^{{cite journal | vauthors = Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, Huber PA | title = Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport | journal = Exp. Cell Res. | volume = 289 | issue = 2 | pages = 211–21 | date = October 2003 | pmid = 14499622 | doi = 10.1016/s0014-4827(03)00261-1 }}
40. ^1 2 3 {{cite journal | vauthors = Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J | title = BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures | journal = Genes Dev. | volume = 14 | issue = 8 | pages = 927–39 | date = April 2000 | pmid = 10783165 | pmc = 316544 | doi = 10.1101/gad.14.8.927}}
41. ^{{cite journal | vauthors = Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y | title = Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression | journal = Mol. Cell. Biol. | volume = 25 | issue = 2 | pages = 661–70 | date = January 2005 | pmid = 15632067 | pmc = 543410 | doi = 10.1128/MCB.25.2.661-670.2005 }}
42. ^{{cite journal | vauthors = Fabbro M, Savage K, Hobson K, Deans AJ, Powell SN, McArthur GA, Khanna KK | title = BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage | journal = J. Biol. Chem. | volume = 279 | issue = 30 | pages = 31251–8 | date = July 2004 | pmid = 15159397 | doi = 10.1074/jbc.M405372200 }}
43. ^{{cite journal | vauthors = Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP, Lavin MF | title = ATM associates with and phosphorylates p53: mapping the region of interaction | journal = Nat. Genet. | volume = 20 | issue = 4 | pages = 398–400 | date = Dec 1998 | pmid = 9843217 | doi = 10.1038/3882 }}
44. ^{{cite journal | vauthors = Westphal CH, Schmaltz C, Rowan S, Elson A, Fisher DE, Leder P | title = Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints | journal = Cancer Res. | volume = 57 | issue = 9 | pages = 1664–7 | date = May 1997 | pmid = 9135004 | doi = }}
45. ^1 2 3 4 5 6 {{cite journal | vauthors = Kim ST, Lim DS, Canman CE, Kastan MB | title = Substrate specificities and identification of putative substrates of ATM kinase family members | journal = J. Biol. Chem. | volume = 274 | issue = 53 | pages = 37538–43 | date = Dec 1999 | pmid = 10608806 | doi = 10.1074/jbc.274.53.37538 }}
46. ^{{cite journal | vauthors = Bao S, Tibbetts RS, Brumbaugh KM, Fang Y, Richardson DA, Ali A, Chen SM, Abraham RT, Wang XF | title = ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses | journal = Nature | volume = 411 | issue = 6840 | pages = 969–74 | date = June 2001 | pmid = 11418864 | doi = 10.1038/35082110 }}
47. ^1 {{cite journal | vauthors = Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff SP, Wu Y, Arlinghaus R, Baltimore D, Gasser PJ, Park MS, Sung P, Lee EY | title = Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl | journal = J. Biol. Chem. | volume = 274 | issue = 18 | pages = 12748–52 | date = April 1999 | pmid = 10212258 | doi = 10.1074/jbc.274.18.12748 }}
48. ^{{cite journal | vauthors = Li S, Ting NS, Zheng L, Chen PL, Ziv Y, Shiloh Y, Lee EY, Lee WH | title = Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response | journal = Nature | volume = 406 | issue = 6792 | pages = 210–5 | date = July 2000 | pmid = 10910365 | doi = 10.1038/35018134 }}
49. ^{{cite journal | vauthors = Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J | title = Rheb binds and regulates the mTOR kinase | journal = Curr. Biol. | volume = 15 | issue = 8 | pages = 702–13 | date = April 2005 | pmid = 15854902 | doi = 10.1016/j.cub.2005.02.053 }}
50. ^{{cite journal | vauthors = Chang L, Zhou B, Hu S, Guo R, Liu X, Jones SN, Yen Y | title = ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 105 | issue = 47 | pages = 18519–24 | date = November 2008 | pmid = 19015526 | pmc = 2587585 | doi = 10.1073/pnas.0803313105 }}
51. ^{{cite journal | vauthors = Kim ST, Xu B, Kastan MB | title = Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage | journal = Genes Dev. | volume = 16 | issue = 5 | pages = 560–70 | date = March 2002 | pmid = 11877376 | pmc = 155347 | doi = 10.1101/gad.970602 }}
52. ^1 {{cite journal | vauthors = Kishi S, Zhou XZ, Ziv Y, Khoo C, Hill DE, Shiloh Y, Lu KP | title = Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks | journal = J. Biol. Chem. | volume = 276 | issue = 31 | pages = 29282–91 | date = August 2001 | pmid = 11375976 | doi = 10.1074/jbc.M011534200 }}
53. ^{{cite journal | vauthors = Fernandez-Capetillo O, Chen HT, Celeste A, Ward I, Romanienko PJ, Morales JC, Naka K, Xia Z, Camerini-Otero RD, Motoyama N, Carpenter PB, Bonner WM, Chen J, Nussenzweig A | title = DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1 | journal = Nat. Cell Biol. | volume = 4 | issue = 12 | pages = 993–7 | date = Dec 2002 | pmid = 12447390 | doi = 10.1038/ncb884 }}
54. ^{{cite journal | vauthors = Ward IM, Minn K, Jorda KG, Chen J | title = Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX | journal = J. Biol. Chem. | volume = 278 | issue = 22 | pages = 19579–82 | date = May 2003 | pmid = 12697768 | doi = 10.1074/jbc.C300117200 }}
55. ^{{cite journal |vauthors=Oikemus SR, McGinnis N, Queiroz-Machado J, Tukachinsky H, Takada S, Sunkel CE, Brodsky MH |title=Drosophila atm/telomere fusion is required for telomeric localization of HP1 and telomere position effect |journal=Genes Dev |volume=18 |issue=15 |pages=1850–61 |date=July 2004 |pmid=15256487 |doi= |url=}}

Further reading

{{Refbegin|35em}}
  • {{cite journal | vauthors = Giaccia AJ, Kastan MB | title = The complexity of p53 modulation: emerging patterns from divergent signals | journal = Genes Dev. | volume = 12 | issue = 19 | pages = 2973–83 | year = 1998 | pmid = 9765199 | doi = 10.1101/gad.12.19.2973 }}
  • {{cite journal | author = Jef Akst | title = Another Telomere-Regulating Enzyme Found | journal = The Scientist | volume = | issue = November 12 | pages = | year = 2015 | pmid = | doi = }}
  • {{cite journal | vauthors = Kastan MB, Lim DS | title = The many substrates and functions of ATM | journal = Nature Reviews Molecular Cell Biology | volume = 1 | issue = 3 | pages = 179–86 | year = 2001 | pmid = 11252893 | doi = 10.1038/35043058 }}
  • {{cite journal | vauthors = Shiloh Y | title = ATM: from phenotype to functional genomics--and back | journal = Ernst Schering Res. Found. Workshop | volume = | issue = 36 | pages = 51–70 | year = 2002 | pmid = 11859564 | doi = }}
  • {{cite journal | vauthors = Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W | title = Histone H2A variants H2AX and H2AZ | journal = Current Opinion in Genetics & Development | volume = 12 | issue = 2 | pages = 162–9 | year = 2002 | pmid = 11893489 | doi = 10.1016/S0959-437X(02)00282-4 }}
  • {{cite journal | vauthors = Tang Y | title = [ATM and Cancer] | journal = Zhongguo Shi Yan Xue Ye Xue Za Zhi | volume = 10 | issue = 1 | pages = 77–80 | year = 2003 | pmid = 12513844 | doi = }}
  • {{cite journal | vauthors = Shiloh Y | title = ATM and related protein kinases: safeguarding genome integrity | journal = Nature Reviews Cancer | volume = 3 | issue = 3 | pages = 155–68 | year = 2003 | pmid = 12612651 | doi = 10.1038/nrc1011 }}
  • {{cite journal | vauthors = Gumy-Pause F, Wacker P, Sappino AP | title = ATM gene and lymphoid malignancies | journal = Leukemia | volume = 18 | issue = 2 | pages = 238–42 | year = 2004 | pmid = 14628072 | doi = 10.1038/sj.leu.2403221 }}
  • {{cite journal | vauthors = Kurz EU, Lees-Miller SP | title = DNA damage-induced activation of ATM and ATM-dependent signaling pathways | journal = DNA Repair (Amst.) | volume = 3 | issue = 8–9 | pages = 889–900 | year = 2005 | pmid = 15279774 | doi = 10.1016/j.dnarep.2004.03.029 }}
  • {{cite journal | vauthors = Abraham RT | title = The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways | journal = DNA Repair (Amst.) | volume = 3 | issue = 8–9 | pages = 919–25 | year = 2005 | pmid = 15279777 | doi = 10.1016/j.dnarep.2004.04.003 }}
  • {{cite journal | vauthors = Lavin MF, Scott S, Gueven N, Kozlov S, Peng C, Chen P | title = Functional consequences of sequence alterations in the ATM gene | journal = DNA Repair (Amst.) | volume = 3 | issue = 8–9 | pages = 1197–205 | year = 2005 | pmid = 15279808 | doi = 10.1016/j.dnarep.2004.03.011 }}
  • {{cite journal | vauthors = Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG | title = ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation | journal = Cell Cycle | volume = 4 | issue = 9 | pages = 1166–70 | year = 2006 | pmid = 16082221 | doi = 10.4161/cc.4.9.1981 }}
  • {{cite journal | vauthors = Ahmed M, Rahman N | title = ATM and breast cancer susceptibility | journal = Oncogene | volume = 25 | issue = 43 | pages = 5906–11 | year = 2006 | pmid = 16998505 | doi = 10.1038/sj.onc.1209873 }}
{{Refend}}

External links

  • http://www.hprd.org/protein/06347
  • Drosophila telomere fusion - The Interactive Fly
  • [https://www.ncbi.nlm.nih.gov/books/NBK26468/ GeneReviews/NCBI/NIH/UW entry on Ataxia telangiectasia]
  • [https://www.ncbi.nlm.nih.gov/omim/271245,607459,301310,208900,607585,208900,607585 OMIM entries on Ataxia telangiectasia]
  • {{UCSC gene info|ATM}}
{{Serine/threonine-specific protein kinases}}{{enzymes}}{{Portal bar|Molecular and Cellular Biology|border=no}}{{DEFAULTSORT:ATM serine threonine kinase}}

2 : Proteins|EC 2.7.11
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/9/25 20:25:16